在帕金森病的发病过程中发挥关键作用的帕金森蛋白:一篇综述
Vidhi Malhotra1, Jaoud Ansari1, Sumaiya Khan1
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.
International journal of biological macromolecules
|August 23, 2025
概括
帕金森病是一种神经退行性疾病, 这篇评论详细介绍了帕金森在细胞健康中的作用及其对帕金森病治疗的影响.
科学领域:
- 神经科学
- 遗传学
- 细胞生物学
背景情况:
- 神经退行性疾病,如帕金森病 (PD),以渐进的神经功能障碍和大脑缩为特征.
- 帕金森病是全球严重的健康问题,全球有600多万病例,是第二常见的神经退行性疾病.
- 在帕金森病中,非运动症状往往先于运动症状的诊断,强调了早期发现和理解的必要性.
研究的目的:
- 在帕金森病的背景下对帕金森蛋白进行全面的审查.
- 阐明帕金蛋白的病理方面,结构,功能和调节.
- 在帕金森病治疗中探索帕金森的治疗潜力.
主要方法:
- 对帕金蛋白的现有研究论文和评论进行文献审查和批判性评估.
- 分析了聚焦于帕金在细胞平衡和泛蛋白酶系统中的作用的研究.
- 关于帕金表达,翻译后修饰和疾病失调的信息综合.
主要成果:
- 通过清除错误折叠和聚合的蛋白质,帕金对维持细胞平衡至关重要,特别是在无素蛋白酶系统中.
- 帕金森基因的突变是自体衰退性帕金森病的主要原因.
- 该审查涵盖了帕金斯的各种方面,包括其病理作用,结构洞察力,功能机制和监管修改.
结论:
- 了解帕金森多方面的作用对于了解帕金森病的发病过程至关重要.
- 帕金森的失调有助于帕金森病的发展和进展.
- 针对帕金森及其途径对治疗帕金森病具有有前途的治疗意义.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.1K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.7K
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
